MORELLO, Silvana
 Distribuzione geografica
Continente #
AS - Asia 5.555
NA - Nord America 4.252
EU - Europa 1.370
SA - Sud America 211
AF - Africa 21
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.417
Nazione #
HK - Hong Kong 4.362
US - Stati Uniti d'America 4.215
SG - Singapore 409
IT - Italia 356
CN - Cina 301
VN - Vietnam 284
RU - Federazione Russa 238
UA - Ucraina 233
BR - Brasile 189
DE - Germania 154
IE - Irlanda 100
SE - Svezia 85
TR - Turchia 70
FI - Finlandia 56
KR - Corea 51
FR - Francia 38
GB - Regno Unito 33
IN - India 21
CZ - Repubblica Ceca 18
CA - Canada 16
MX - Messico 15
PL - Polonia 11
ZA - Sudafrica 11
AT - Austria 10
PH - Filippine 10
BD - Bangladesh 9
ES - Italia 9
JP - Giappone 8
NL - Olanda 7
AR - Argentina 5
CO - Colombia 4
DK - Danimarca 4
PE - Perù 4
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
IL - Israele 3
IQ - Iraq 3
IR - Iran 3
JO - Giordania 3
LT - Lituania 3
MA - Marocco 3
SA - Arabia Saudita 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EC - Ecuador 2
EU - Europa 2
HU - Ungheria 2
ID - Indonesia 2
JM - Giamaica 2
KE - Kenya 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
UZ - Uzbekistan 2
BT - Bhutan 1
CM - Camerun 1
GA - Gabon 1
KZ - Kazakistan 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.417
Città #
Hong Kong 4.360
Ann Arbor 992
Chandler 487
Woodbridge 415
Wilmington 295
Jacksonville 290
Princeton 275
Dong Ket 271
Houston 232
Dallas 186
Singapore 177
Dublin 98
Ashburn 97
Izmir 64
Nanjing 64
Munich 61
Andover 58
Beijing 58
Boardman 57
Moscow 56
Salerno 54
Pellezzano 46
The Dalles 27
Fairfield 26
Los Angeles 26
Columbus 25
Redwood City 22
Shenyang 22
Hebei 20
Brno 16
Norwalk 16
Tianjin 16
Nanchang 15
Falls Church 14
Jiaxing 13
Santa Clara 13
São Paulo 13
Guangzhou 12
Naples 12
Council Bluffs 11
Dearborn 11
Milan 11
Pune 11
Warsaw 11
Changsha 10
Chicago 10
Nuremberg 10
Rome 10
San Francisco 10
Boston 9
Fisciano 9
New York 9
San Diego 9
Seattle 9
Washington 9
Avellino 8
Brooklyn 8
Düsseldorf 8
Ischia 8
Turku 8
Ho Chi Minh City 7
Johannesburg 7
Napoli 7
Tokyo 7
Jinan 6
Lessolo 6
London 6
Sarno 6
Belo Horizonte 5
Cambridge 5
Castellammare di Stabia 5
Florence 5
Mestre 5
Ottawa 5
Campinas 4
Genova 4
Giugliano In Campania 4
Hanoi 4
Lappeenranta 4
Montreal 4
Phoenix 4
Rio de Janeiro 4
Roccapiemonte 4
Saponara 4
Spin 4
Stockholm 4
Vienna 4
Amman 3
Brescia 3
Clifton 3
Dalian 3
Edinburgh 3
Esslingen am Neckar 3
Florianópolis 3
Fuzhou 3
Helsinki 3
Mascalucia 3
Mexico City 3
Recife 3
Shanghai 3
Totale 9.373
Nome #
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model 1.341
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab 857
Adenosine A(2A) receptor agonist, CGS21680, inhibits inflammation and increases FGF-2 tissue expression in carrageenin induced rat paw edema 446
Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target 338
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients 274
High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells 243
Gastric TFF1 Expression from Acute to Chronic Helicobacter Infection 238
Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5′-Nucleotidase (CD73) 230
Targeting adenosine A2b receptor reduces melanoma progression in mice: role of tumor-associated MDSCs 205
The CD73 is induced by TGF-β1 triggered by nutrient deprivation and highly expressed in dedifferentiated human melanoma 195
Anxa1 contained in evs regulates macrophage polarization in tumor microenvironment and promotes pancreatic cancer progression and metastasis 190
B Cells contribute to the Anti-tumour Activity of CpG-ODN in a Mouse Model of Metastatic Lung Carcinoma 179
Design and expression of peptides with antimicrobial activity against Salmonella typhimurium 178
Insertion of a 59 amino acid peptide in Salmonella Typhimurium membrane results in loss of virulence in mice 169
Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+ T Cells Reduces Melanoma Growth in Mice. 163
NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model. 162
The Activation of Liver X Receptor Inhibits Toll-Like Receptor-9-Induced Foam Cell Formation 153
Design and In Vivo Anti-Inflammatory Effect of Ketoprofen Delayed Delivery Systems 152
Adenosine A2a receptor agonists as regulators of inflammation: pharmacology and therapeutic opportunities 148
Role of plasmacytoid dendritic cells in lung-associated inflammation. 148
Antiproliferative activity of brown Cuban propolis extract on human breast cancer cells 145
Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma 145
Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. 139
Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model. 138
Antiadrenergic effect of adenosine involves connexin 43 turn-over in H9c2 cells 136
The adenosinergic system in cancer: Key therapeutic target 133
Adenosine receptors as potential targets in melanoma 131
Microbiologia Molecolare e Cellulare 130
Cl-IB-MECA enhances TNF-α release in peritoneal macrophages stimulated with LPS. 124
Therapeutic potential of a pyridoxal-based vanadium(IV) complex showing selective cytotoxicity for cancer versus healthy cells 121
Prednisolone Delivery Platforms: Capsules and Beads Combination for a Right Timing Therapy 118
H3K56 acetylation affects Candida albicans morphology and secreted soluble factors interacting with the host 117
A peptide activating protease activated receptor 2 (PAR2) modulates vascular responses to phenylephrine in vitro and in vivo. 113
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression. 112
A protective role for proteinase activated receptor 2 in airways of lipopolysaccharide-treated rats 112
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 110
Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation 108
Adenosine signalling mediates the anti-inflammatory effects of the COX-2 inhibitor nimesulide. 106
Cytotoxic activity of nemorosone in human MCF-7 breast cancer cells 105
Soluble CD73 in the peripheral blood: a potential biomarker in patients with advanced melanoma receiving nivolumab 105
Lung cancer and Toll-like receptors. 103
Adenosine A(2A) receptor activation inhibits inflammation and reduce c-Fos activation in carrageenin-induced rat paw oedema 102
A general procedure to generate novel antimicrobial peptides and their use to obtain attenuated strains active as vaccine 101
Interleukin-17A Exacerbates Ferric Chloride-Induced Arterial Thrombosis in Rat Carotid Artery 100
Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma. 98
Airway Hyperresposiveness to adenosine in ovalbumin sensitized wistar rats 96
CD73: A Promising Biomarker in Cancer Patients 91
Myeloid cells in the tumor microenvironment: role of adenosine 90
3D printed macroporous scaffolds of PCL and inulin-g-P(D,L)LA for bone tissue engineering applications 89
Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells 88
CpG-ODN increases the release of VEGF in a mouse model of lung carcinoma. 86
Haemostatic imbalance following carrageenan-induced rat paw oedema. 85
Plasmacytoid dendritic cells alter the antitumor activity of CpG-oligodeoxynucleotides in a mouse model of lung carcinoma. 85
Plasmacytoid dendritic cells: from heart to vessels. 85
The A2B adenosine receptor: an emerging therapeutic target in cancer 83
Expression of CD73 on CD8+/PD-1+cells as a new possible biomarker for advanced melanoma patients treated with nivolumab 83
Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells 83
Adenosine Signaling in the Tumor Microenvironment 79
Insight into adenosine pathway in psoriasis: Elucidating its role and the potential therapeutical applications 78
Polyinosinic-polycytidylic Acid limits tumor outgrowth in a mouse model of metastatic lung cancer. 78
Spiro[(dihydropyrazin-2,5-dione)-6,3′-(2′,3′- dihydrothieno[2,3-b]naphtho-4′,9′-dione)]-based cytotoxic agents: Structure-activity relationship studies on the substituent at N4-position of the diketopiperazine domain 76
Hyperresponsiveness to adenosine in sensitized Wistar rats over-expressing A(1) receptor. 74
Adenosine A2A receptor agonist, 2-p-(2-Carboxyethyl) phenethylamino-5′-N-ethylcarboxamidoadenosine hydrochloride hydrate, inhibits inflammation and increases fibroblast growth factor-2 tissue expression in carrageenan- Induced rat paw edema 74
IL-1beta and TNF-{alpha} Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-{kappa}B Binding to the Proximal Promoter 72
Pharmacological dissection of vascular effects caused by activation of protease activated receptors 1 and 2 in anesthetized rats 70
Basal nitric oxide modulates vascular effects of a peptide activating protease-activated receptor 2 69
Low copper availability limits Helicobacter infection in mice 69
Vascular effects of caffeic acid phenethyl ester (CAPE) on isolated rat thoracic aorta 66
Expression of CD73 on MDSCs and CD8+/PD-1+cells as new possible biomarkers for advanced melanoma patients treated with nivolumab 59
Notch Signaling Regulates Mitochondrial Metabolism and NF-kappa B Activity in Triple-Negative Breast Cancer Cells via IKK alpha-Dependent Non-canonical Pathways 59
Enzyme activity of circulating CD73 in human serum 58
Zinc and calcium cations combination in the production of floating alginate beads as prednisolone delivery systems 57
Ecto-5ʹ-nucleotidase (CD73): an emerging role as prognostic factor in allergic sensitization 56
Vasorelaxant effect of the flavonoid galangin on isolated rat thoracic aorta 56
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents 56
Differential regulation of A2A adenosine receptor expression in human epithelial cells by IL-1b and TNF-a 54
Polysaccharides based gastroretentive system to sustain piroxicam release: Development and in vivo prolonged anti-inflammatory effect 49
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy 48
Lack of Ecto-5′-Nucleotidase Protects Sensitized Mice against Allergen Challenge 48
Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity 46
Thrombo-Inflammation: A Focus on NTPDase1/CD39 40
The combination of mesoglycan and VEGF promotes skin wound repair by enhancing the activation of endothelial cells and fibroblasts and their cross-talk 38
The pyrazolyl-urea gege3 inhibits the activity of ANXA1 in the angiogenesis induced by the pancreatic cancer derived EVs 35
The Ecto-5'-Nucleotidase/CD73 Inhibitor, α,β-Methylene Adenosine 5'-Diphosphate, Exacerbates Carrageenan-Induced Pleurisy in Rat 32
A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice 31
Diamond nanoneedles for biosensing 12
Signaling Pathways in Inflammation and Its Resolution: New Insights and Therapeutic Challenges 9
Totale 11.653
Categoria #
all - tutte 31.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.733


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021747 0 46 49 3 64 40 82 14 57 8 80 304
2021/2022521 1 0 19 3 20 24 8 28 67 67 62 222
2022/20231.025 83 98 37 151 112 197 3 114 143 7 57 23
2023/2024388 32 61 31 18 20 60 5 25 2 20 12 102
2024/20251.236 55 14 20 77 63 176 236 90 163 45 148 149
2025/20264.751 2.085 2.666 0 0 0 0 0 0 0 0 0 0
Totale 11.653